Referred to the House Committee on the Judiciary.
The bill removes any federal statutory immunity or liability limits that would protect manufacturers of COVID-19 vaccines from civil suits, explicitly overriding federal provisions that grant such protections. It preserves individuals' ability to seek compensation through the Countermeasures Injury Compensation Program and the National Vaccine Injury Compensation Program, and allows civil suits even after pursuing those programs.
Progressives emphasize public-health chilling effects versus conservative emphasis on accountability
Substantive removal of established liability shields is politically and technically controversial; likely strong stakeholder opposition despite narrow subject.
The bill removes any federal statutory immunity or liability limits that would protect manufacturers of COVID-19 vaccines from civil suits, explicitly overriding federal provisions that grant such protections.
It preserves individuals' ability to seek compensation through the Countermeasures Injury Compensation Program and the National Vaccine Injury Compensation Program, and allows civil suits even after pursuing those programs.
The bill defines "COVID-19 vaccine" and applies its rule retroactively to past, present, and future administrations or uses of such vaccines.
Directly reverses established federal liability protections for vaccines, raises substantial legal, public‑health, and industry pushback; simple text but legally fraught and politically polarizing.
How solid the drafting looks.
Progressives emphasize public-health chilling effects versus conservative emphasis on accountability
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize public-health chilling effects versus conservative emphasis on accountability
Overall skeptical.
The persona will worry the bill undermines public-health preparedness by removing liability protections that encouraged rapid vaccine production during emergencies.
They also value victims' compensation and transparency, so they may support stronger accountability but worry about chilling effects on future vaccine development.
Mixed but pragmatic.
The persona recognizes the importance of accountability for harms while also worrying about unintended consequences for public health supply and preparedness.
They would look for procedural safeguards, time limits, or targeted liability standards to balance remedies and emergency incentives.
Supportive.
The persona will value removing federal immunity as restoring individual legal rights and corporate accountability.
They view liability shields as excessive government protection of industry and support opening courts to injured Americans, while accepting some concern about impacts on supply as secondary.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Directly reverses established federal liability protections for vaccines, raises substantial legal, public‑health, and industry pushback; simple text but legally fraught and politically polarizing.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize public-health chilling effects versus conservative emphasis on accountability
Directly reverses established federal liability protections for vaccines, raises substantial legal, public‑health, and industry pushback; s…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for LIABLE Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.